Hereditary angioedema (HAE) is a chronic condition that may cause painful swelling in your skin, abdomen, and other parts of your body. Hereditary angioedema (HAE) causes episodes of angioedema, a ...

Deficiency of functional C1-INH activity is an autosomal dominant genetic disorder that can be further classified into 2 types. Type I HAE, which accounts for approximately 85% of cases, occurs due to ...

IONS secures EU approval for Dawnzera in hereditary angioedema, after FDA clearance in the United States in August last year.

Hereditary angioedema (HAE) is a rare genetic condition that causes swelling under the skin and lining of your gut and lungs. “Angio” means it affects your blood vessels. “Edema” means swelling. So ...

The European Medicines Authority’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for a new drug to treat hereditary angioedema (HAE).

Angioedema is deep tissue swelling that may occur due to various health conditions. Treating angioedema swelling depends on the cause. Angioedema may be acute or chronic, and acute symptoms may last ...

Please provide your email address to receive an email when new articles are posted on . Patients fit into one of four groups based on monthly hereditary angioedema attacks before lanadelumab. Along ...

Ionis Pharma & Otsuka’s donidalorsen gets approval in European Union for hereditary angioedema: Carlsbad, California Saturday, January 24, 2026, 13:00 Hrs [IST] Ionis Pharmaceut ...

Pharvaris, a biopharmaceutical company based in Zug, Switzerland, announced that abstracts for multiple presentations have been accepted for the 2025 National Summit of the US Hereditary Angioedema ...